Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and Safety of Pembrolizumab plus Axitinib combination for Metastatic Renal Cell Carcinoma in a Real-World Scenario: Data From the Prospective ProPAXI Study.
Guida A, Gili A, Mosillo C, Maruzzo M, Lai E, Pierantoni F, Bimbatti D, Basso U, Fornarini G, Rebuzzi SE, Calabrò F, Cerbone L, Caserta C, Sirgiovanni G, Serafin D, Caffo O, Scagliarini S, Bracarda S. Guida A, et al. Among authors: sirgiovanni g. Clin Genitourin Cancer. 2024 Sep 14;22(6):102225. doi: 10.1016/j.clgc.2024.102225. Online ahead of print. Clin Genitourin Cancer. 2024. PMID: 39405768
The 5-WS of targeting DNA-damage repair (DDR) pathways in prostate cancer.
Guida A, Mosillo C, Mammone G, Caserta C, Sirgiovanni G, Conteduca V, Bracarda S. Guida A, et al. Among authors: sirgiovanni g. Cancer Treat Rev. 2024 Jul;128:102766. doi: 10.1016/j.ctrv.2024.102766. Epub 2024 May 17. Cancer Treat Rev. 2024. PMID: 38763054 Review.
TROP-2, NECTIN-4 and predictive biomarkers in sarcomatoid and rhabdoid bladder urothelial carcinoma.
Brunelli M, Gobbo S, Malpeli G, Sirgiovanni G, Caserta C, Munari E, Francesconi S, Caliò A, Martignoni G, Cimadamore A, Veccia A, Antonelli A, Tucci M, Pierconti F, Hattab IM, Eccher A, Ascani S, Milella M, Buffoni L, Cheng L, Bracarda S. Brunelli M, et al. Among authors: sirgiovanni g. Pathologica. 2024 Feb;116(1):55-61. doi: 10.32074/1591-951X-937. Pathologica. 2024. PMID: 38482675 Free PMC article.
Circulating Natural Killer Cells as Prognostic Value for Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors: Correlation with Sarcopenia.
Tenuta M, Pandozzi C, Sciarra F, Campolo F, Gelibter AJ, Sirgiovanni G, Cortesi E, Lenzi A, Isidori AM, Sbardella E, Venneri MA. Tenuta M, et al. Among authors: sirgiovanni g. Cancers (Basel). 2023 Jul 12;15(14):3592. doi: 10.3390/cancers15143592. Cancers (Basel). 2023. PMID: 37509255 Free PMC article.
Impact of Sarcopenia and Inflammation on Patients with Advanced Non-Small Cell Lung Cancer (NCSCL) Treated with Immune Checkpoint Inhibitors (ICIs): A Prospective Study.
Tenuta M, Gelibter A, Pandozzi C, Sirgiovanni G, Campolo F, Venneri MA, Caponnetto S, Cortesi E, Marchetti P, Isidori AM, Sbardella E. Tenuta M, et al. Among authors: sirgiovanni g. Cancers (Basel). 2021 Dec 17;13(24):6355. doi: 10.3390/cancers13246355. Cancers (Basel). 2021. PMID: 34944975 Free PMC article.
The 5-Ws of immunotherapy in head and neck cancer.
Botticelli A, Mezi S, Pomati G, Cerbelli B, Di Rocco C, Amirhassankhani S, Sirgiovanni G, Occhipinti M, Napoli V, Emiliani A, Mazzuca F, Tomao S, Nuti M, Marchetti P. Botticelli A, et al. Among authors: sirgiovanni g. Crit Rev Oncol Hematol. 2020 Sep;153:103041. doi: 10.1016/j.critrevonc.2020.103041. Epub 2020 Jun 30. Crit Rev Oncol Hematol. 2020. PMID: 32629362 Review.
Adjuvant chemotherapy in resected colon cancer: When, how and how long?
Gelibter AJ, Caponnetto S, Urbano F, Emiliani A, Scagnoli S, Sirgiovanni G, Napoli VM, Cortesi E. Gelibter AJ, et al. Among authors: sirgiovanni g. Surg Oncol. 2019 Sep;30:100-107. doi: 10.1016/j.suronc.2019.06.003. Epub 2019 Jul 2. Surg Oncol. 2019. PMID: 31500770 Review.